Synexa Insights
The Latest Insights From Our Scientists
Using Exosomes As Clinical Biomarkers
Emerging biomarker solutions apply the use of exosomes to clinical applications due to their role in the immune system and blood-brain barrier.…
A Brief Introduction To Novel Modalities
Novel modalities can be used in new biologics to treat complex diseases that have previously been untreatable with therapy. Read…
Enhancing PCR Molecular Diagnostics Using Immunoassays
Immunoassays play a crucial role in identifying and monitoring diseases, as well as determining the most appropriate treatment for those…
How to Measure Bacteriophages in Clinical Studies for Antimicrobial Agents
Bacterio refers to “bacteria” and phage to “eat”, thus bacteriophages are viruses that grow on bacteria by attaching to the…
How to Accelerate Pre-Clinical Trials with Flow Cytometry
Flow cytometry is a powerful analytical method for various applications in pre-clinical and clinical research. It is used in cell…
What are Immune Checkpoint Inhibitors?
Diseases, especially cancer, suppress the immune system and compromise the body’s biological mechanisms needed to defend itself from the disease…
Where Does Bioanalysis Fit into Drug Discovery Pipelines?
Bioanalysis is foundational for investigational therapeutic agents. This blog post will define the bioanalysis of molecules and highlight its beneficial…
A Quick Guide to Biomarker Solutions
Biomarker solutions cover a range of technologies, from modern diagnostic tools which make biological traits accessible, to analytical systems underpinning…
Fibrosis and SMAD signalling
During normal physiological wound healing, inflammation, angiogenesis and fibrogenesis are all effectively controlled, so that once sufficient matrix has accumulated…
Lipids as Biomarkers of Brain Disorders
Whilst the role of lipids has been particularly relevant within cardiovascular disease, their abundance in the body and high prevalence…
Synexa raises awareness for Rare Diseases Day
28 February 2022 marks Rare Disease Awareness Day and here at Synexa Life Sciences we are sharing our colours to…
The Biomarker Association between Depression and Vascular Disease
Major depressive disorder (MDD) has repeatedly emerged as a confounding or prognostic factor in the development of cardiovascular pathologies and…
Infertility and the importance of the endometrial immune balance
Infertility is defined by the World Health Organisation as the inability of a sexually active non-contracepting couple, to conceive after…
Improving the quality of human health
Contact us
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline
